Technology ID
E-274-2013-0

Methods of Detecting and Identifying Both Known and Novel Influenza Viruses

Linked ID
TAB-2644
Inventors
Suxiang (Sue) Tong (CDC)
Lead Inventors
Suxiang (Sue) Tong (CDC)
Development Status
  • Pre-clinical
  • In vitro data available
Applications
Diagnostics
Therapeutic Areas
Infectious Disease
ICs
CDC
Commercial Applications
  • Method of rapid, accurate subtype-screening of influenza viruses using "pan-influenza" RT-PCR
  • Diagnostic tool for clinicians, veterinarians, public health programs, food-safety officials, researchers and forensic scientists
This invention describes materials and methods of detecting novel influenza virus in a sample. As highlighted by the recent H1N1 pandemic strain, influenza viruses are constantly evolving and novel reassortments can quickly spread around the world.

The reagents and methods of this particular technology are capable of detecting any type of influenza virus (such as influenza A virus, influenza B virus, and influenza C virus) in a sample, including novel or previously unknown influenza viruses. Such methods and compositions are useful for diagnosing influenza virus infection in humans and animals.
Competitive Advantages
  • A full-spectrum, sensitive and specific assay for identification of influenza viruses, known and novel
  • Easily adaptable for commercial production

Request More Info

Licensing Contact